Literature DB >> 2451896

Interferon induction by SMANCS: a polymer-conjugated derivative of neocarzinostatin.

F Suzuki1, T Munakata, H Maeda.   

Abstract

Poly (styrene-co-maleic acid)-conjugated neocarzinostatin, SMANCS, induced antiviral activities in the circulation of mice. The maximum titer of the activity (240 U/ml) was observed 20 h after administration an 8 mg/kg iv dose of SMANCS. Various experiments showed that this antiviral substance induced by SMANCS was an interferon (IFN). Sixty percent of the IFN response stimulated by SMANCS was impaired in mice pretreated with anti-IFN gamma antiserum. This suggests that the serum IFN induced by the agent contained about 60% of IFN gamma. When Thy 1+ or Lyt 2+ T-cells were depleted from mice by administration of anti-Thy 1.2 or anti-Lyt 2.2 monoclonal antibody (mAb), this IFN response was eliminated. However, when natural killer cells were depleted from mice by treatment with antiasialo GM1 antiserum, no alteration in the IFN response was observed. The SMANCS-stimulated IFN response was also abrogated in mice treated with macrophage blockers (carrageenan and trypan blue), whereas administration of anti-Lyt 1.2 mAb had no effect on the IFN response. These results suggest that macrophage and T-cells w Lyt 1-2+ phenotype may have an important role in the IFN response stimulated by SMANCS.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2451896

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Synthesis and evaluation of poly(styrene-co-maleic acid) micellar nanocarriers for the delivery of tanespimycin.

Authors:  Nate Larson; Khaled Greish; Hillevi Bauer; Hiroshi Maeda; Hamidreza Ghandehari
Journal:  Int J Pharm       Date:  2011-08-12       Impact factor: 5.875

2.  Antitumor resistance induced by zinostatin stimalamer (ZSS), a polymer-conjugated neocarzinostatin (NCS) derivative. I. Meth A tumor eradication and tumor-neutralizing activity in mice pretreated with ZSS or NCS.

Authors:  E Masuda; H Maeda
Journal:  Cancer Immunol Immunother       Date:  1995-05       Impact factor: 6.968

3.  Stimulation of non-specific resistance to tumors in the mouse using a poly(maleic-acid-styrene)-conjugated neocarzinostatin.

Authors:  F Suzuki; R B Pollard; H Maeda
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Synthesis and therapeutic effect of styrene-maleic acid copolymer-conjugated pirarubicin.

Authors:  Kenji Tsukigawa; Long Liao; Hideaki Nakamura; Jun Fang; Khaled Greish; Masaki Otagiri; Hiroshi Maeda
Journal:  Cancer Sci       Date:  2015-02-03       Impact factor: 6.716

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.